In vitro metabolism of the glucagon-like peptide-1 (GLP-1)-derived metabolites GLP-1 (9-36) amide and GLP-1 (28-36) amide in mouse and human hepatocytes
Retatrutide is developed by Eli Lilly, the company behind tirzepatide (Mounjaro/Zepbound)
However, some patients undergoing TRT may experience elevated blood pressure as a side effect
Injecting subcutaneously through a needle too short for the client
Unfortunately, the test proved to be too complicated and unwieldly for many patients and their clinicians as it required "an overnight fast, ingestion of (modestly) radioactive cobalamin, a 24-hour collection of urine, a cobalamin injection, two trips to the laboratory, and, if the result [was] abnormal, repetition of the entire procedure with a dose of [intrinsic factor]" (45)